0001703057-24-000002.txt : 20240116
0001703057-24-000002.hdr.sgml : 20240116
20240116181423
ACCESSION NUMBER: 0001703057-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240114
FILED AS OF DATE: 20240116
DATE AS OF CHANGE: 20240116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hansen Carl L. G.
CENTRAL INDEX KEY: 0001834412
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 24536318
MAIL ADDRESS:
STREET 1: C/O ABCELLERA BIOLOGICS INC.
STREET 2: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbCellera Biologics Inc.
CENTRAL INDEX KEY: 0001703057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
BUSINESS PHONE: (604) 559-9005
MAIL ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
4
1
wk-form4_1705446854.xml
FORM 4
X0508
4
2024-01-14
0
0001703057
AbCellera Biologics Inc.
ABCL
0001834412
Hansen Carl L. G.
C/O ABCELLERA BIOLOGICS INC
2215 YUKON STREET
VANCOUVER
A1
BRITISH COLUMBIA, CANADA
1
1
1
0
Chief Executive Officer
0
Share option (right to buy)
5.39
2024-01-14
5
A
0
E
2095532
0
A
2034-01-14
Common Shares
2095532
8484723
D
The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
Tryn Stimart, attorney-in-fact
2024-01-16